![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Janssen Pharmaceutical Ltd County Cork Ie, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Haloperidol, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-179 - Rev 01
This Chemical Type CEP, issued on March 12, 2002, remains in force until June 14, 2004, ensuring its reliability within the pharmaceutical industry.
Substance Number 616 associated with this CEP further emphasizes